Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TOMRA: Change in Executive Leadership Team

Harald Henriksen has been appointed EVP, Head of TOMRA Food as Michel Picandet is stepping down from the position with immediate effect. Harald has served as EVP, Head of TOMRA Collection since 2016, and has held various roles within the TOMRA Collection division since joining TOMRA in 2004. "I'm very pleased to have Harald lead TOMRA Food into the future. Harald has extensive commercial experience, deep technological knowledge and has successfully led TOMRA Collection’s profitable expansion into new markets over the last seven years. I also want to thank Michel for leading TOMRA Food

Swedavia’s traffic statistics for May 2023

The recovery in aviation continued in May, and summer travel is now picking up speed. In May, for the first time since the start of the Covid pandemic, Swedavia’s airports had more than 3 million passengers in a single month. That is an increase of 14 per cent compared to May last year and corresponds to 83 per cent of the pre-pandemic level. Demand for international flights in Europe remains strong, with the trend driven by airline investments in enhanced connectivity mostly via Stockholm Arlanda Airport. In conjunction with the Ascension Day holiday in late May, Arlanda reached its

Viaplay Group downgrades outlook for 2023 and appoints new CEO

Viaplay Group (“the Group”) today announced a downgrade of its short-term outlook for 2023 following an accelerated deterioration in the operating environment and longer than expected realisation of its cost savings programme. The Group has also withdrawn its long term operational and financial guidance. An update on the medium term outlook is expected to be provided in conjunction with the publication of the Group’s Q2 results on 20 July 2023. Group CEO Anders Jensen has today offered his resignation. The Board of Directors has accepted Anders’s resignation, and is pleased to announce the

BAKKAFROST: Capital Markets Day Webcast - 6 June 2023

On Tuesday 6 June 2023, Bakkafrost will have it's Capital Markets Day 2023. The Capital Markets Day will start with a main presentation, followed by a Q&A session. This presentation will also be available as webcast. Bakkafrost has arranged site visits in connection with the Capital Markets Day. Presentations giving more insight into Bakkafrost operations and 5-year plan for 2024-2028 are held at the site visits. All presentations are included in the Capital Markets Day presentation, which will be available on www.bakkafrost.com/en/investor-relations/reports-and-presentations.WEBCAST

SimCorp A/S - Major shareholder announcement

June 4, 2023 Company announcement no.12/2023Pursuant to Section 30 of the Capital Markets Act, please be informed that SimCorp A/S on June 2, 2023, was informed by BLS Capital Fondsmæglerselskab A/S that BLS Capital Fondsmæglerselskab A/S now holds 4.33% of the voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800).

Breaking Financial News: Your Key to Market Success

What are the latest financial developments?We are proud to introduce MyntNews, a comprehensive news and information platform that provides traders and investors with accurate, unbiased, and objective news With the market rebounding, now is the time to invest in your future. If you want to stay ahead in trading, MyntNews can assist you in achieving this. MyntNews is an element of the MyntExchange trading platform and MyntEcosystem, which is dedicated to delivering personalized news tailored to your interests and preferences. Comprehensive and up-to-date information is essential for

CHOSA Oncology AB publishes results from clinical phase 2 trial of liposomal formulation in breast cancer, using predictive marker for cisplatin

[En bild som visar text, skärmbild, Teckensnitt, nummer Automatiskt genererad beskrivning]   CEO Peter Buhl comments: “CHOSA presents these important findings that have crystallized by deep clinical knowledge and years of dedication to developing LiPlaCis and its response prediction test DRP”.   We welcome interaction and look forward to discussing this at the ASCO poster session that opens today:   Abstract number and title: 3130; Predictive biomarker for cisplatin in prospective phase 2 of liposomal cisplatin in metastatic breast cancerSession: Developmental

Communication from Polymer Factory Sweden AB’s Annual General Meeting 2023

Annual General Meeting in Polymer Factory Sweden AB (publ) was held 2 June 2023, 13.00 at the Company’s premises. Summarized below are the most important decisions from the Annual General Meeting.Adoption of the profit and loss statement and the balance sheetThe Annual General Meeting adopted the profit and loss statement and the balance sheet for the Company for the financial year 2022. The company’s profits or losses according to the adopted balance sheetThe Annual General Meeting resolved that the Company’s results shall be carried forward in new account and that no dividend shall

Reporting of transactions made by persons discharging managerial responsibilities

SUGAR LAND, TEXAS, June 2, 2023 /CNW/ - Noble Corporation plc ("Noble") (CSE: NOBLE, NYSE: NE) today announces that the persons listed below (the "PDMRs") have conducted transactions in the A ordinary shares of Noble each with a nominal value of USD 0.00001. Further details are set out in the notifications below, made in accordance with the requirements of article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (the "Market Abuse Regulation") as amended.   Notification and public disclosure in accordance with the

Lundin Mining Announces Filing of 2022 ESTMA Report

Toronto, June 2, 2023 /CNW/ (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) announces the filing of its 2022 Extractive Sector Transparency Measures Act (ESTMA) Report, which can be found on the Company’s website at lundinmining.com/investors/corporate-filings/. The information in this release is subject to the disclosure requirements of Lundin Mining under the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact persons set out below on June 2, 2023 at 17:00 Eastern Time. View

Nordea Bank Abp: Repurchase of own shares on 02.06.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares02.06.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 02.06.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |33,583 |9.45 |317,433.23

DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

The Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Tuesday, 20 June 2023 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, 6823 Ansager, Denmark The agenda for the extraordinary general meeting is as follows: 1. 1. 1. 1. 1. 1. 1. Proposed resolution to authorise the Board of Directors to increase the share capital without pre-emption rights for the Company’s shareholders. (proposed by the board of directors)

Imfinzi improved pCR in gastric and GEJ cancers

2 June 2023 Imfinzi plus chemotherapy significantly improved pathologic complete response in gastric and gastroesophageal junction cancers in MATTERHORN Phase III trial First global Phase III trial of immunotherapy and chemotherapy combination to demonstrate clinical benefit in this settingTrial will continue to assess event-free survival Positive high-level results from a planned interim analysis of the MATTERHORN Phase III trial showed treatment with AstraZeneca's Imfinzi (durvalumab) added to standard-of-care FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel)

First ever in Europe: full-duration upper stage hot-fired at Esrange Space Center by RFA

For the first time in Europe, and second time worldwide, a privately developed staged combustion upper stage has been successfully hot-fired. The test was performed at Esrange Space Center in northern Sweden, owned and operated by Swedish Space Corporation (SSC), by German rocket company Rocket Factory Augsburg (RFA). The upper stage hot-fired for a full duration of 280 seconds at the company’s testbed facility.A milestone for SSC and the unique testbed infrastructure of Esrange. Esrange is today one of few places worldwide with the capability to host full duration stage testing of

Bittium Corporation: SHARE REPURCHASE 2.6.2023

Bittium Corporation  ANNOUNCEMENT  2.6.2023 Bittium Corporation: SHARE REPURCHASE 2.6.2023 In the Helsinki Stock Exchange Trade date           2.6.2023Bourse trade         BuyShare                  BITTIAmount             2 900 SharesAverage price/ share    4,1346 EURTotal cost            11 990,34 EUR Bittium Corporation now holds a total of 13 484 sharesincluding the shares repurchased on 2.6.2023 On behalf of Bittium Corporation Nordea Bank Oyj

Fodelia Oyj: Share Repurchase 2.6.2023

Fodelia Oyj Announcement  2.6.2023 Fodelia Oyj: Share Repurchase 2.6.2023 In the Helsinki Stock Exchange Trade date           2.6.2023Bourse trade         BuyShare                  FODELIAAmount             1 020 SharesAverage price/ share    4,3372 EURTotal cost            4 423,94 EUR Fodelia Oyj now holds a total of 12 831 sharesincluding the shares repurchased on 2.6.2023 On behalf of Fodelia Oyj Nordea Bank Oyj Janne Sarvikivi

NRC Group ASA – Transactions made under the share buyback program

Reference is made to the stock exchange notice announcement from NRC Group ASA (the “Company”) of 24 May 2023 regarding the buyback program of up to NOK 7 million. The current program is valid until 30 June 2023. From 24 May 2023 until 2 June 2023, the Company has purchased a total of 150,788 own shares at the Oslo Stock Exchange. A detailed overview of all completed transactions under the buyback program carried out during the above time period is attached hereto. At present date, NRC Group ASA owns 267,444 treasury shares in the Company, corresponding to 0.37% of the share capital.

DanCann Pharma A/S Secures 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants

COPENHAGEN, Denmark, 02 June 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has secured a financing agreement with Nordic Growth Opportunities 2 (the “Investor”), according to which the Company will receive up to DKK 18.9 million over the next 12 months and potentially additional proceeds if warrants are exercised by the Investor. The agreement is a 10-year financing loan agreement with 12 months conversion option and including warrants. The agreement is furthermore subject

Enviro’s Chairman and CEO represent the company on the board of new joint venture

The Chairman of Scandinavian Enviro Systems AB (publ) ("Enviro" or the "Company"), Alf Blomqvist, and the company’s CEO, Thomas Sörensson, have been appointed to represent Enviro on the board of the new joint venture. The joint venture’s first board meeting was held on June 1, 2023.The joint venture was formed by Enviro and Antin Infrastructure Partners to establish the world’s first large-scale tire recycling company based on Enviro’s technology. As previously announced, the joint venture is planning to establish plants across Europe by 2030 with a total recycling capacity of one million

DanCann Pharma receives approximately DKK 5.6 million from the exercise of series TO 2 together with a directed issue to the underwriters

COPENHAGEN, Denmark, 02 June 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, today announces the outcome of the exercise of warrants of series TO2 (the “Warrants”) and a directed issue of shares. A total of 5,854,594 TO 2 warrants were exercised, corresponding to an exercise rate of approximately 27 percent. Prior to the exercise period, the Company also agreed on underwriting from external investors regarding the warrants that are not exercised by the warrant holders up to 71 percent of TO 2 warrants. Therefore, the

Neste supports Rio Tinto U.S. Borax mining site to transition to renewable diesel

Neste Corporation, News, 2 June 2023  Photo: Rio Tinto U.S. Borax Mine in Boron, California. Source: Rio TintoNeste has partnered with Rio Tinto to help the company transition all of its heavy machinery from fossil diesel to renewable diesel at the U.S. Borax mine in Boron, California. The partnership helps Rio Tinto reduce the carbon footprint of its fleet and sets a precedent for others in the mining industry to follow.Rio Tinto’s initial trial of switching fossil diesel to renewable diesel in a haul truck was conducted in 2022 in partnership with Neste and Rolls-Royce. Rio

Inside information: Citycon changes the payment and record dates for the quarterly distribution in June

CITYCON OYJ   Inside information   2 June 2023 at 18:00 hrsThe Board of Directors of Citycon Oyj has decided to change the payment date and record date for the quarterly distribution in June. The original dates were published in a stock exchange release on 4 May 2023.  The new record date is 16 June 2023 (previously 23 June 2023), and the new payment date is 26 June 2023 (previously 30 June 2023). The amount of the equity repayment remains unchanged (EUR 0.125 per share).Following the asset distribution on 26 June 2023, Citycon Oyj has distributed a total equity repayment of EUR 0.25 per

#23-186 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

There are no items matching the current filter
There are no more items matching the current filter
Back to top